Inactive Instrument

Biondvax Pharmaceuticals Ltd Stock

Stocks

End-of-day quote TEL AVIV STOCK EXCHANGE
- ^ILa	-

19-07-16	Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	PU
19-07-08	Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	PU
19-06-26	Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	PU
19-06-18	Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	PU
19-06-10	Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	PU

Manager	Title	Age	Since
Amir Reichman CEO	Chief Executive Officer	51	2021-03-01
Uri Ben-Or DFI	Director of Finance/CFO	55	2006-12-31
Dalit Fischer CTO	Chief Tech/Sci/R&D Officer	-	2021-12-31

Director	Title	Age	Since
Mark Germain CHM	Chairman	77	2019-09-29
Samuel Moed BRD	Director/Board Member	64	2020-03-23
Adi Raviv BRD	Director/Board Member	71	2020-03-23

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-0.03%	+6.41%	+11.83%	+38.36%	49.06B
IQVIA HOLDINGS INC.	-0.73%	-0.33%	+49.81%	+36.06%	44.6B
REVOLUTION MEDICINES, INC.	+1.36%	+6.08%	+365.57%	+624.08%	43.24B
BEONE MEDICINES AG	-0.47%	-0.04%	+12.10%	+98.46%	41.73B
CELLTRION, INC.	+0.34%	-1.38%	+5.53%	+47.36%	29.93B
MEDPACE HOLDINGS, INC.	+1.00%	-0.33%	+25.23%	+152.51%	17.19B
TEMPUS AI, INC.	-2.94%	+5.83%	+5.22%	-	15.35B
EUROFINS SCIENTIFIC SE	-3.20%	-2.38%	+25.00%	+43.67%	15.54B
ASCENDIS PHARMA A/S	-0.86%	-4.01%	-	-	15.11B
Average	-0.61%	+2.36%	+62.54%	+148.64%	30.19B
Weighted average by Cap.	-0.27%	+2.42%	+78.64%	+162.88%

Employees

Sector